USFDA grants full approval for Abbvie Elahere for certain ovarian cancer patients Ruchika Sharma23 March 2024 1:15 PM ISTNorth Chicago, Ill.: AbbVie has announced that the U.S. Food and Drug Administration (FDA) has granted full approval for ELAHERE...
AbbVie, OSE Immunotherapeutics collaborate to develop novel monoclonal antibody for Chronic Inflammation Ruchika Sharma3 March 2024 10:00 AM ISTUnder the terms of the agreement, AbbVie will receive an exclusive global license to develop, manufacture and commercialize OSE-230.
AbbVie, Tentarix collaborate to develop conditionally-active, multi-specific biologics for oncology, immunology Ruchika Sharma25 Feb 2024 12:45 PM ISTNorth Chicago: AbbVie Inc. and Tentarix Biotherapeutics have announced a multi-year collaboration focused on the discovery and development of...
AbbVie concludes acquisition of ImmunoGen Ruchika Sharma14 Feb 2024 4:36 PM ISTNorth Chicago, Ill.: AbbVie has announced that it has completed its acquisition of ImmunoGen. With the completion of the acquisition,...
AbbVie unveils Produodopa for Advanced Parkinson's Disease in EU Ruchika Sharma14 Jan 2024 1:00 PM ISTNorth Chicago, III.: AbbVie has announced the launch of PRODUODOPA (foslevodopa/foscarbidopa) in the European Union for the treatment of advanced...
AbbVie, Umoja Biopharma collaborate to develop Novel In-Situ CAR-T Cell Therapies Ruchika Sharma8 Jan 2024 10:00 AM ISTNorth Chicago: AbbVie, and Umoja Biopharma, an early clinical-stage biotechnology company, have announced two exclusive option and license...
Botox rival Revance loses bid to dismiss Allergan trade secrets lawsuit Ruchika Sharma5 Jan 2024 4:15 PM ISTUnited States: A federal judge on Wednesday said Botox maker AbbVie's Allergan unit can move ahead with its lawsuit accusing Revance...
CVS Health to remove AbbVie rheumatoid arthritis drug Humira from some drug reimbursement lists in April Ruchika Sharma4 Jan 2024 12:30 PM ISTA CVS spokesperson said the company expects most of its customers to transition their coverage to biosimilars of Humira, known chemically as...
AbbVie to focus on smaller deals after buying spree Ruchika Sharma9 Dec 2023 2:30 PM ISTAbbVie said it expects to return to "robust growth" in 2025, after its recent buying spree.
AbbVie to acquire Cerevel Therapeutics for USD 8.7 billion Ruchika Sharma8 Dec 2023 12:30 PM ISTNorth Chicago: AbbVie Inc. and Cerevel Therapeutics have announced a definitive agreement under which AbbVie will acquire Cerevel Therapeutics and its...
AbbVie to acquire ImmunoGen, including its flagship cancer therapy Elahere Ruchika Sharma4 Dec 2023 11:30 AM ISTNorth Chicago, Ill.: AbbVie Inc. and ImmunoGen, Inc. have announced a definitive agreement under which AbbVie will acquire ImmunoGen, and its flagship...
Turkey launches investigation into 19 pharma cos Ruchika Sharma1 Dec 2023 12:49 PM ISTAnkara: Turkey's competition authority said on Thursday it had launched an investigation into 19 pharmaceutical companies to determine whether they...
